The effect of renal phosphate clearance on serum fibroblats growth factor 23 (FGF23) in patients on peritonela dialysis
Not Applicable
- Conditions
- Endstage renal disease
- Registration Number
- JPRN-UMIN000009315
- Lead Sponsor
- Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Serum levels of FGF23 was negatively associated with residual renal function in patients on peritoneal dialysis, after adjusted for the potential confounders.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did receive peritoneal dialysis thearapy more than 30 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method